Correlation Between Kempharm and Denali Therapeutics

By analyzing existing cross correlation between Kempharm and Denali Therapeutics, you can compare the effects of market volatilities on Kempharm and Denali Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Kempharm with a short position of Denali Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Kempharm and Denali Therapeutics.

Specify exactly 2 symbols:

Can any of the company-specific risk be diversified away by investing in both Kempharm and Denali Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Kempharm and Denali Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.

Diversification Opportunities for Kempharm and Denali Therapeutics

0.91
  Correlation Coefficient
Kempharm
Denali Therapeutics

Almost no diversification

The 3 months correlation between Kempharm and Denali is 0.91. Overlapping area represents the amount of risk that can be diversified away by holding Kempharm and Denali Therapeutics in the same portfolio assuming nothing else is changed. The correlation between historical prices or returns on Denali Therapeutics and Kempharm is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Kempharm are associated (or correlated) with Denali Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Denali Therapeutics has no effect on the direction of Kempharm i.e., Kempharm and Denali Therapeutics go up and down completely randomly.

Pair Corralation between Kempharm and Denali Therapeutics

Given the investment horizon of 90 days Kempharm is expected to generate 9.61 times more return on investment than Denali Therapeutics. However, Kempharm is 9.61 times more volatile than Denali Therapeutics. It trades about 0.05 of its potential returns per unit of risk. Denali Therapeutics is currently generating about 0.08 per unit of risk. If you would invest  71.00  in Kempharm on June 29, 2021 and sell it today you would earn a total of  808.00  from holding Kempharm or generate 1138.03% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Strong
Accuracy99.4%
ValuesDaily Returns

Kempharm  vs.  Denali Therapeutics

 Performance (%) 
      Timeline 
Kempharm 
 Kempharm Performance
0 of 100
Over the last 90 days Kempharm has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's basic indicators remain nearly stable which may send shares a bit higher in October 2021. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Kempharm Price Channel

Denali Therapeutics 
 Denali Performance
0 of 100
Over the last 90 days Denali Therapeutics has generated negative risk-adjusted returns adding no value to investors with long positions. Despite unfluctuating performance in the last few months, the Stock's essential indicators remain nearly stable which may send shares a bit higher in October 2021. The current disturbance may also be a sign of long-run up-swing for the company stockholders.

Denali Price Channel

Kempharm and Denali Therapeutics Volatility Contrast

 Predicted Return Density 
      Returns 

Pair Trading with Kempharm and Denali Therapeutics

The main advantage of trading using opposite Kempharm and Denali Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Kempharm position performs unexpectedly, Denali Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Denali Therapeutics will offset losses from the drop in Denali Therapeutics' long position.
The idea behind Kempharm and Denali Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center. Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try Balance Of Power module to check stock momentum by analyzing Balance Of Power indicator and other technical ratios.

Other Complementary Tools

Financial Widgets
Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets
Go
Focused Opportunities
Build portfolios using our predefined set of ideas and optimize them against your investing preferences
Go
Price Exposure Probability
Analyze equity upside and downside potential for a given time horizon across multiple markets
Go
Portfolio Holdings
Check your current holdings and cash postion to detemine if your portfolio needs rebalancing
Go
Equity Valuation
Check real value of public entities based on technical and fundamental data
Go